Athira Pharma (ATHA) Earnings Date & Reports

Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ATHA is expected to report earnings to fall 4.35% to -21 cents per share on August 18

Athira Pharma ATHA Stock Earnings Reports

Q2'25

Est.

$-0.22

Q1'25

Missed

by $0.05

Q4'24

Est.

$-0.38

Q3'24

Missed

by $0.05

Q2'24

Beat

by $0.04

The last earnings report on May 09 showed earnings per share of -23 cents, missing the estimate of -18 cents. With 60.48K shares outstanding, the current market capitalization sits at 9.93M.

View a ticker or compare two or three

Compare

ATHA